Nicole Zhang

9PUBLICATIONS
69CO-AUTHORS
Molecular targetsHealth and ecological risk assessmentPredictive and prognostic markersPreventative health careCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 01, 2026
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

|Feb 26, 2026
Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-Resistant Prostate Cancer.

Chinmay T Jani, Eli Tran, Nicole Zhang

|Feb 07, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.

Tadashi Manabe, Hannah C Bergo, Qingtian Li

|Nov 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.

Tadashi Manabe, Hannah C Bergo, Qingtian Li

|Nov 07, 2025
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.

Maxwell R Lloyd, Caroline M Weipert, Azka Ali

|May 05, 2025
Assessment of Circulating Tumor DNA Burden in Patients With Metastatic Gastric Cancer Using Real-World Data.

Senaka A Peter, Razvan Cristescu, Carol Peña

Pageof 2

Frequent Collaborators

2 joint publications

Elifnur Yay Donderici

2 joint publications

Shaun P Forbes

2 joint publications

Victoria M Raymond

2 joint publications

Amar K Das